blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3548610

EP3548610 - NK-MEDIATED IMMUNOTHERAPY AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.11.2022
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  26.11.2021
FormerGrant of patent is intended
Status updated on  11.08.2021
FormerExamination is in progress
Status updated on  02.03.2020
FormerRequest for examination was made
Status updated on  06.09.2019
FormerThe international publication has been made
Status updated on  08.06.2018
Formerunknown
Status updated on  04.12.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Fondazione Ri.MED
Via Bandiera 11
90133 Palermo / IT
For all designated states
Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione . ISMETT
Via Discesa dei Giudici 4
90133 Palermo (PA) / IT
[2019/41]
Inventor(s)01 / BADAMI, Ester
Fondazione Ri.MED
Via Bandiera 11
90133 Palermo (PA) / IT
 [2019/41]
Representative(s)Capasso, Olga
De Simone & Partners S.r.l.
Via Vincenzo Bellini, 20
00198 Roma / IT
[2021/52]
Former [2019/41]Trillat, Anne-Cecile, et al
De Simone & Partners S.p.A.
Via Vincenzo Bellini, 20
00198 Roma / IT
Application number, filing date17803974.929.11.2017
[2019/41]
WO2017EP80848
Priority number, dateIT2016012108129.11.2016         Original published format: IT201600121081
[2019/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018099988
Date:07.06.2018
Language:EN
[2018/23]
Type: A1 Application with search report 
No.:EP3548610
Date:09.10.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2018 takes the place of the publication of the European patent application.
[2019/41]
Type: B1 Patent specification 
No.:EP3548610
Date:29.12.2021
Language:EN
[2021/52]
Search report(s)International search report - published on:EP07.06.2018
ClassificationIPC:A61P35/00, C12N5/0783
[2021/29]
CPC:
C12N5/0646 (EP,US); A61K35/17 (EP,US); A61K45/06 (US);
A61P35/00 (EP,US); C12N2501/2302 (EP,US); C12N2501/2312 (EP);
C12N2501/2315 (EP,US); C12N2501/2318 (EP); C12N2501/24 (EP,US) (-)
Former IPC [2019/41]C12N5/0783
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/41]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NK-VERMITTELTE IMMUNTHERAPIE UND VERWENDUNGEN DAVON[2019/41]
English:NK-MEDIATED IMMUNOTHERAPY AND USES THEREOF[2019/41]
French:IMMUNOTHÉRAPIE MÉDIÉE PAR NK ET SES UTILISATIONS[2019/41]
Entry into regional phase03.06.2019National basic fee paid 
03.06.2019Designation fee(s) paid 
03.06.2019Examination fee paid 
Examination procedure03.06.2019Amendment by applicant (claims and/or description)
03.06.2019Examination requested  [2019/41]
03.06.2019Date on which the examining division has become responsible
05.03.2020Despatch of a communication from the examining division (Time limit: M04)
14.07.2020Reply to a communication from the examining division
23.07.2020Despatch of a communication from the examining division (Time limit: M02)
29.09.2020Reply to a communication from the examining division
14.10.2020Despatch of a communication from the examining division (Time limit: M04)
28.12.2020Reply to a communication from the examining division
03.02.2021Despatch of a communication from the examining division (Time limit: M04)
28.05.2021Reply to a communication from the examining division
12.08.2021Communication of intention to grant the patent
10.11.2021Fee for grant paid
10.11.2021Fee for publishing/printing paid
10.11.2021Receipt of the translation of the claim(s)
Opposition(s)30.09.2022No opposition filed within time limit [2022/49]
Fees paidRenewal fee
05.11.2019Renewal fee patent year 03
26.11.2020Renewal fee patent year 04
18.11.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.11.2017
AL29.12.2021
AT29.12.2021
CY29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
MC29.12.2021
MK29.12.2021
MT29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
[2024/42]
Former [2024/27]HU29.11.2017
AL29.12.2021
AT29.12.2021
CY29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
MC29.12.2021
MK29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2024/21]HU29.11.2017
AL29.12.2021
AT29.12.2021
CY29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
MC29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2024/18]HU29.11.2017
AL29.12.2021
AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
MC29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2023/31]AL29.12.2021
AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
MC29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2023/10]AL29.12.2021
AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SI29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2022/49]AL29.12.2021
AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2022/42]AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
IS29.04.2022
PT29.04.2022
Former [2022/36]AT29.12.2021
CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
PL29.12.2021
RO29.12.2021
RS29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
PT29.04.2022
Former [2022/35]CZ29.12.2021
EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
RO29.12.2021
RS29.12.2021
SK29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
PT29.04.2022
Former [2022/34]EE29.12.2021
ES29.12.2021
FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
RO29.12.2021
RS29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
PT29.04.2022
Former [2022/33]FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
RS29.12.2021
SM29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
Former [2022/25]FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
RS29.12.2021
BG29.03.2022
NO29.03.2022
GR30.03.2022
Former [2022/24]FI29.12.2021
HR29.12.2021
LT29.12.2021
LV29.12.2021
RS29.12.2021
BG29.03.2022
GR30.03.2022
Former [2022/22]FI29.12.2021
LT29.12.2021
RS29.12.2021
BG29.03.2022
Former [2022/21]RS29.12.2021
BG29.03.2022
Former [2022/19]BG29.03.2022
Cited inInternational search[A]WO2012089736  (APEIRON BIOLOGICS AG [AT], et al);
 [A]WO2016020434  (JOHANN WOLFGANG GOETHE UNIVERSITÄT [DE]);
ExaminationWO2013119118
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.